The Patent Finder

Terms ending in 2030

Amarin Pharma, Inc.

Every in-force patent on Amarin Pharma, Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,563,608Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 11,439,618Compositions and Methods for Lowering Triglycerides
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 11,464,757Compositions and Methods for Lowering Triglycerides
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 11,712,428Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
In force
 · Medium confidence
Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 11,712,429Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
In force
 · Medium confidence
Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 12,171,738Compositions and Methods for Lowering Triglycerides
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 8,410,086Compositions and Methods for Lowering Triglycerides
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 8,710,041Compositions and Methods for Lowering Triglycerides in a Subject on Concomitant Statin Therapy
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 10,842,768Compositions and Methods for Lowering Triglycerides
In force
 · Medium confidence
Amarin Pharmaceuticals Ireland LimitedIn forceMedium confidence
US 8,298,554Stable Pharmaceutical Composition and Methods of Using Same
In force
 · High confidence
Amarin Pharmaceuticals Ireland LimitedIn forceHigh confidence
1 more term end in 2030 · Pro
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
Upgrade to Pro
2 of these are in force and held by Amarin Pharma, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited